FDA advisory committee endorses GSK’s malaria drug tafenoquine
The Antimicrobial Drugs Advisory Committee (AMDAC) of the United States Food and Drug Administration (FDA) has given a unanimous nod to GlaxoSmithKline’s (GSK) malaria drug, tafenoquine. This endorsement marks a significant milestone for the single-dose drug aimed at treating and preventing the relapse of Plasmodium vivax (P. vivax) malaria in patients aged 16 years and […]